Global Breast Biopsy Market

Breast Biopsy Market Insights

A breast biopsy is a procedure to diagnose breast cancer. The procedure involves initially a test to remove tissue or fluid present in the suspicious area of the patient. The removed sample is then sent for further examination of breast cancer to the laboratory. This is not restricted to cancer but also for ailments of breasts such as lumps present in the breast. A wide variety of methods are present in the market for the early stages of detection. A breast biopsy is usually conducted using minimal invasive biopsy systems to provide minimal disfigurement and pain.

As per the GME report on the breast biopsy market, it is estimated that the market is expected to show significant growth at a CAGR of 8.5% during the 2020-2026 period. The rising incidence of breast cancer percentage and growing demand for minimally invasive procedures is building the demand for the breast biopsy market. New product launch and rising breast cancer screening programs is triggering the demand of breast biopsy market. Technical advancements and an increase in the expenditure of companies towards breast cancer research studies are driving the growth of the market. However high cost involved in the procedure and associated side effects of the treatment are the major concern growing as a restraint factor for the breast biopsy market. 

Breast Biopsy Market: By Product

Liquid biopsy instruments, assay kits, localized wires, biopsy tables, guidance systems, biopsy needles, and others are the classification of the breast biopsy market based on the type of product used for the technique. The biopsy needles are expected to dominate the breast biopsy market in the forecast period. The rising adoption of image-guided approach and launch of technologically advanced and novel designs in developing countries is propelling the market of the breast biopsy techniques.

Breast Biopsy Marke: By Type

The types of breast biopsy can be studied as circulating tumor DNA (cDNA), circulating tumor cells, liquid breast biopsy instrument, incisional, excisional, open surgical breast biopsy, vacuum-assisted biopsy (VAB), fine-needle aspiration biopsy (FNAB). The liquid breast biopsy is anticipated to show the highest breast biopsy market in the coming years owing to the growing adoption of NGS based assay and drop digital PCR technology to perform the liquid biopsy in economically stable regions. Companies are more inclined towards investing in this technique thus creating a create opportunity to target a higher volume of the market.

Breast Biopsy Market: By Guidance

The Guidance of the breast biopsy can be explained as microarray-based biopsy, PCR-based biopsy, NGS-based biopsy, liquid biopsy, MRI-guided biopsy, ultrasound-guided biopsy, mammography-guided stereotactic biopsy, image-guided biopsy, and other guidance technique. Image-guided biopsy has evolved as the fastest-growing domain of the market as the procedure is minimally invasive and shows excellent accuracy as open surgical biopsies. It is preferred over other techniques as it is safer specifically for patients with breast micro-calcifications.

Breast Biopsy Market: By Application

Recurrence monitoring, treatment monitoring, therapy selection, and early cancer screening are the applications covered by breast biopsy and early cancer screening is the dominating among all the applications. The reason behind the significant growth of the market is the increasing prevalence of breast cancer, growing awareness among customers about early detection of the cancer is triggering the early cancer screening segment market in recent times.

Breast Biopsy Market: By Region

APAC is the highest growing region of the breast biopsy market and is expected to maintain the market growth momentum in the projected period as well. The rising healthcare sector in economically developing countries and growing investment for the development of advanced technology is triggering the market share of the APAC region of breast biopsy. Also increasing breast cancer issues in the region with growing awareness of the early detection programs in the patients is accelerating the growth of the market in the region. Government investment in the R&D sector for research on breast cancer-based studies is creating opportunities for the breast biopsy market in recent times.  

Breast Biopsy Market Share and Competitor Analysis

The key players operating in the market include Exact Sciences Corporation, Hologic, Inc., and Becton, Dickinson and Company, QIAGEN, Illumina, Inc., Danaher Corporation, Medtronic, IZI Medical Product, Argon Medical, STERYLAB S.r.l., Scion, LLC, Biocept Inc., Bio-Rad Laboratories, Inc., Medical Technologies, F. Hoffmann-La Roche Ltd, Menarini Silicon Biosystems, Spa, and Thermo Fisher Scientific, Inc., among others.

Please note: This is not an exhaustive list of companies profiled in the report.

In October 2020, Hologic launched 3DQuorumimaging technology powered by Genius AI. The innovation aims to improve mammography efficiency to manage the previous pile-ups of breast screening routine due to COVID19 lockdown.

In October 2020, Hologic came up with a multi-year program in partnership with Black Women's Health Imperative (BWHI).